Position in LH
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$656,320
-$99,285 QoQ
Shares Held
2,344
-17.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#528
of 1,040 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $23,504,396 across 18 Diagnostics & Research names. LH ranks #13 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
8,944 | $4,484,163 | |
| 2 | ILMN |
Illumina, Inc.
|
20,400 | $3,586,932 | |
| 3 | DHR |
Danaher Corp /De/
|
10,912 | $2,078,517 | |
| 4 | A |
Agilent Technologies, Inc.
|
13,470 | $1,789,220 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
7,243 | $1,642,639 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
7,946 | $1,535,326 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
2,406 | $1,266,614 | |
| 8 | DGX |
Quest Diagnostics Inc
|
5,557 | $1,177,806 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $656,320 | 2,344 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $755,605 | 2,832 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $934,778 | 3,726 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,078,484 | 3,757 | Shares | Sole | 2025-11-06 | |
| 2025-03-31 | $509,467 | 2,189 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,236,952 | 5,394 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $927,442 | 4,150 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $851,689 | 4,185 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||